Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Shockwave Medical Inc (NQ: SWAV )

210.15 -4.87 (-2.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Shockwave Medical Inc

< Previous 1 2 3 4 5 6 Next >
Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait 10 Years
Patient investors who would like to see their investments rise 10x have some interesting options right now. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023
 
Via Benzinga
Expert Ratings for ShockWave Medical
 
Via Benzinga
3 Supercharged Stocks That Still Look Unstoppable
You don't need boatloads of money to start investing in these high-quality stocks. 
Via The Motley Fool
5 Analysts Have This to Say About ShockWave Medical
 
Via Benzinga
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
ShockWave Medical's Earnings Outlook
 
Via Benzinga
Where ShockWave Medical Stands With Analysts
 
Via Benzinga
ShockWave Medical Earnings Perspective: Return On Capital Employed
 
Via Benzinga
5 Big Earning Beats Making These Stocks a Buy
Not all earnings beats are created equal. Only those with sustainable business models deserve to be on your investment radar. 
Via InvestorPlace
3 Exceptional Growth Stocks That Could Shoot 28.3% to 40.6% Higher, According to Wall Street
Big gains could lie ahead if the rest of the market begins looking at these stocks in the same light as the investment bank analysts who follow them. 
Via The Motley Fool
A Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and Hold
This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
2 Beaten-Down Growth Stocks to Buy Now Before They Start Soaring Again
After falling 73% and 38% from their previous peaks, these beaten-down growth stocks are trading at sensible valuations. 
Via The Motley Fool
Shockwave Medical Just Tripled Profit Expectations, Delivering 991% Growth
The company also beat sales expectations, meeting the high end of its outlook. 
Via Investor's Business Daily
Shockwave Medical Shares Gain As Q4 Earnings Surpass Wall Street Expectations
 
Via Benzinga
ShockWave Medical (SWAV) Q4 2022 Earnings Call Transcript
SWAV earnings call for the period ending December 31, 2022. 
Via The Motley Fool
3 Pharma Stocks That Will Mint Millionaires
These pharma stocks all have excellent risk-reward ratios and the companies have developed treatments that could easily become blockbusters. 
Via InvestorPlace
3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023
These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses. 
Via The Motley Fool
Why Neovasc Shares Are Trading Higher Today
Neovasc Inc. (NASDAQ: NVCN) shares are trading higher after ShockWave Medical, Inc. (NASDAQ: SWAV) announced it would acquire the company. 
Via Benzinga
Shockwave Medical Seeks To Bolster Its Cardiovascular Disease Portfolio With Neovasc Acquisition
 
Via Benzinga
How Doug Godshall Ignited The Spark At Shockwave
ShockWave Medical CEO Doug Godshall says successful companies don't follow a formula. 
Via Investor's Business Daily
2 Elite Growth Stocks Ready for a Bull Run in 2023
It's going to take more than a recession to stop these two from delivering outsized gains to patient investors. 
Via The Motley Fool
Nasdaq Bear Market: 3 Unstoppable Growth Stocks to Buy at Knocked-Down Prices
The road ahead of these businesses is a lot smoother than you'd think by looking at their stock prices. 
Via The Motley Fool
7 Index Funds to Buy to Retire a Millionaire
Although the market shows signs of improvement, the waters are still choppy enough for investors to focus on index funds to buy. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
 
Via Benzinga
3 Beaten-Down Growth Stocks That Billionaires Are Buying With Both Hands
Some of the world's most successful investors can't get enough of The Trade Desk, Shockwave Medical, and SoFi Technologies. 
Via The Motley Fool
$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years
Long-term investors should consider the high upside of these growth stocks. 
Via The Motley Fool
InMode Stock Shows Improved Technical Strength; Hits Key Technical Threshold
The Relative Strength (RS) Rating for InMode stock moved up into a higher percentile Wednesday, as it got a lift from 64 to 78. 
Via Investor's Business Daily
This Stock Is Up 106% In 2022 And Analysts Love It, But Jim Cramer Says 'There's Too Much Political Risk'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is a "very early stage company that has a lot in the pipe. I tend to like these companies." 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.